Landscape Capital Management, L.L.C. Apellis Pharmaceuticals, Inc. Transaction History
Landscape Capital Management, L.L.C.
- $1.01 Billion
- Q1 2025
A detailed history of Landscape Capital Management, L.L.C. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Landscape Capital Management, L.L.C. holds 38,988 shares of APLS stock, worth $950,137. This represents 0.08% of its overall portfolio holdings.
Number of Shares
38,988
Previous 49,986
22.0%
Holding current value
$950,137
Previous $1.6 Million
46.58%
% of portfolio
0.08%
Previous 0.19%
Shares
3 transactions
Others Institutions Holding APLS
# of Institutions
285Shares Held
124MCall Options Held
921KPut Options Held
761K-
Wellington Management Group LLP Boston, MA12.3MShares$300 Million0.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.2MShares$298 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$290 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$247 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$235 Million0.02% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.68B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...